Katayoon Pakravan

738 citations
17 papers · 590 indexed · h-index 11
Topics
Extracellular vesicles in disease (10 papers)MicroRNA in disease regulation (10 papers)Circular RNAs in diseases (6 papers)
Partner nations
IranChinaIraq

In The Last Decade

Katayoon Pakravan

17 papers receiving 585 citations

Peers

Katayoon Pakravan
Comparison fields: 5 of 61
  • Molecular Biology 492
  • Cancer Research 399
  • Oncology 72
  • Immunology 53
  • Genetics 50
Replace Xinhui Liu with:
Xinhui Liu China
Yafei Dai China
Samuel D. Rose United States
Kar Lok Kong Hong Kong
Yong Yi China
Qing Yao China
Xueqiang Ding China
Hideaki Oe Japan
Xiaoying Xue China
Katayoon Pakravan relative to Xinhui Liu China Xinhui Liu's profile →
Citations per field
00.5×1.5×2.4×
Xinhui Liu · 1×
Citations per year

Countries citing papers authored by Katayoon Pakravan

Since Specialization
Citations

This map shows the geographic impact of Katayoon Pakravan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katayoon Pakravan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katayoon Pakravan more than expected).

Fields of papers citing papers by Katayoon Pakravan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katayoon Pakravan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katayoon Pakravan. The network helps show where Katayoon Pakravan may publish in the future.

Co-authorship network of co-authors of Katayoon Pakravan

This figure shows the co-authorship network connecting the top 25 collaborators of Katayoon Pakravan. A scholar is included among the top collaborators of Katayoon Pakravan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katayoon Pakravan. Katayoon Pakravan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
#WorkIndexed citations
1 6
2 13
3 10
4 6
5 13
6 34
7 41
8 10
9 48
10 32
11 14
12 10
13 289
14 14
15
Isolation, Characterization and Cellular Uptake of Exosomes Derived from Bone Marrow Mesenchymal Stem Cells
4
16 21
17
Therapeutic application of mesenchymal stem cell-derived exosomes: A promising cell-free therapeutic strategy in regenerative medicine.
25

About Katayoon Pakravan

Katayoon Pakravan is a scholar working on Cancer Research, Molecular Biology and Immunology, having authored 17 papers that have together received 590 indexed citations. Recurring topics across this work include Extracellular vesicles in disease (10 papers), MicroRNA in disease regulation (10 papers) and Circular RNAs in diseases (6 papers). The work is most often cited by research in Cancer Research (399 citations), Molecular Biology (492 citations) and Genetics (50 citations). Katayoon Pakravan has collaborated with scholars based in Iran, China and Iraq. Frequent co-authors include Sadegh Babashah, Majid Mossahebi‐Mohammadi, Majid Sadeghizadeh, Mohammad Javan, Seyed Javad Mowla, Farangis Ataei, Nasim Dana, Ehsan Razmara, William C. Cho and Babak Bakhshinejad. Their work appears in journals such as Biochemical Pharmacology, Life Sciences and BMC Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026